Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 10/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 5: Figure S5

Description: Differentially abundant taxa between the TB and TB + HRZ groups at 4months HR therapy(termination of therapy).

Abundance in Group 1: decreased abundance in TB +HRZ group - 4months HR(W20)

NCBI	Quality Control	Links
Robinsoniella
Ethanoligenens
Ruminococcus
Acetanaerobacterium
Dorea
Pseudobutyrivibrio
Anaerovorax
Marvinbryantia
Tyzzerella
Mucispirillum
Asaccharobacter
Erysipelotrichaceae
Roseburia
Ruminiclostridium
Eubacterium
Turicibacter
Roseivirga
Acetatifactor
Dysgonomonas
Butyricimonas
Lachnospiraceae
Parabacteroides

Revision editor(s): KateRasheed